Skip Navigation


Human Molecular Genetics Advance Access originally published online on March 11, 2008
Human Molecular Genetics 2008 17(12):1855-1866; doi:10.1093/hmg/ddn081
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Supplementary Data
Right arrow All Versions of this Article:
17/12/1855    most recent
ddn081v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Huang, Y.
Right arrow Articles by van der Maarel, S. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Huang, Y.
Right arrow Articles by van der Maarel, S. M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2008. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Calpain 3 is a modulator of the dysferlin protein complex in skeletal muscle

Yanchao Huang1,{dagger}, Antoine de Morrée1,{dagger}, Alexandra van Remoortere2, Kate Bushby3, Rune R. Frants1, Johan Tden Dunnen1 and Silvère M. van der Maarel1,*

1 Center for Human and Clinical Genetics 2 Department of Parasitology, Leiden University Medical Center, Leiden, The Netherlands 3 Institute of Human Genetics, International Centre for Life, Newcastle-upon-Tyne, UK

* To whom correspondence should be addressed at: Center for Human and Clinical Genetics, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands. Tel: +3171 5269480; Fax: +31 71526 8285; Email: maarel{at}lumc.nl

Received January 17, 2008; Accepted March 9, 2008

Muscular dystrophies comprise a genetically heterogeneous group of degenerative muscle disorders characterized by progressive muscle wasting and weakness. Two forms of limb-girdle muscular dystrophy, 2A and 2B, are caused by mutations in calpain 3 (CAPN3) and dysferlin (DYSF), respectively. While CAPN3 may be involved in sarcomere remodeling, DYSF is proposed to play a role in membrane repair. The coexistence of CAPN3 and AHNAK, a protein involved in subsarcolemmal cytoarchitecture and membrane repair, in the dysferlin protein complex and the presence of proteolytic cleavage fragments of AHNAK in skeletal muscle led us to investigate whether AHNAK can act as substrate for CAPN3. We here demonstrate that AHNAK is cleaved by CAPN3 and show that AHNAK is lost in cells expressing active CAPN3. Conversely, AHNAK accumulates when calpain 3 is defective in skeletal muscle of calpainopathy patients. Moreover, we demonstrate that AHNAK fragments cleaved by CAPN3 have lost their affinity for dysferlin. Thus, our findings suggest interconnectivity between both diseases by revealing a novel physiological role for CAPN3 in regulating the dysferlin protein complex.


{dagger} The authors wish it to be known that, in their opinion, the first two authors should be regarded as joint First Authors.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Hum Mol GenetHome page
I. Kramerova, E. Kudryashova, B. Wu, S. Germain, K. Vandenborne, N. Romain, R. G. Haller, M. A. Verity, and M. J. Spencer
Mitochondrial abnormalities, energy deficit and oxidative stress are features of calpain 3 deficiency in skeletal muscle
Hum. Mol. Genet., September 1, 2009; 18(17): 3194 - 3205.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
Y.-H. Chiu, M. A. Hornsey, L. Klinge, L. H. Jorgensen, S. H. Laval, R. Charlton, R. Barresi, V. Straub, H. Lochmuller, and K. Bushby
Attenuated muscle regeneration is a key factor in dysferlin-deficient muscular dystrophy
Hum. Mol. Genet., June 1, 2009; 18(11): 1976 - 1989.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.